Skip to content
General News, Medical Health Aged Care

CDU EXPERT: Bans on surrogacy has not stopped it, but merely increased the risk for vulnerable women, expert says

Charles Darwin University < 1 mins read

19 JULY 2023

There is a lot of incentive for couples to seek a surrogate from a low-to-medium income country.  Recent bans in these targeted countries are not stopping the trade, but just forcing vulnerable women to cross borders for medical treatment.  Surrogacy expert Dr Ju Attawet has studied the industry for years and is available for comment.

As appeared in 360: https://360info.org/ban-wont-stop-transnational-surrogacy/

Dr Ju Attawet, Lecturer in Nursing and surrogacy expert, Charles Darwin University

Contact details: +61 8 8946 6529 or email us at media@cdu.edu.au to arrange an interview.

The following quotes can be attributed to Dr Attawet:

“Women are forced to cross borders to be part of a surrogacy, and often this is to countries with poor health care and support.”

“There are many reasons why couples will use a surrogate in another country, but for the surrogate its often because they desperately need the money.”

“We have seen in the past that without the right support, surrogacy can be a disastrous experience that can contribute to psychological health and wellbeing.”

“Increased regulations and support, instead of outright banning commercial surrogacy locally, could stop the cross-border trade.”

“Protecting women is the role of both governments and NGOs, and an outright ban does little to protect anyone except those agencies that can profit for desperate people by exploiting them further.”


Contact details:

Emily Bostock
Acting Research Communications Officer
T: +61 8 8946 6529
M: 0432 417 518
E:
media@cdu.edu.au

More from this category

  • Medical Health Aged Care
  • 31/10/2024
  • 12:10
MannKind

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

ICoN-1 study presentation planned November 1 at NTM Symposium AustraliaStudy is cleared by health authorities to proceed in Australia, U.S., Japan and South Korea, with Taiwan anticipated by end of year DANBURY, Conn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it has initiated its first site for its Phase 3 clinical trial evaluating efficacy and safety of Clofazimine Inhalation Suspension for the treatment of nontuberculous mycobacterial (NTM) lung disease. The study,…

  • Education Training, Medical Health Aged Care
  • 31/10/2024
  • 11:30
UNSW Sydney

Record donation awarded to UNSW Sydney will enable the Kirby Institute and partners to advance cervical cancer elimination in the Pacific

Media Release 01.00AM AEDT, Friday 1 November 2024 Record donation awarded to UNSW Sydney will enable the Kirby Institute and partners to advance cervical cancer elimination in the Pacific A $25.9 million donation from the Swire Group will support cervical cancer screening and treatment for over 130,000 women in seven Pacific countries. UNSW Sydney has received the largest single philanthropic donation in its history to work with regional partners to tackle one of the deadliest preventable cancers in the Pacific. The $25.9 million donation from the Swire Group will enable UNSW’s Kirby Institute to work with partners in Australia and…

  • Contains:
  • General News, Women
  • 31/10/2024
  • 11:08
McDougall Media

New Empower Her Campaign to help women into the workforce

New Empower Her Campaign to help women into the workforce A new campaign from national charity Dress for Success is striving to help thousands…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.